Document Detail

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
MedLine Citation:
PMID:  22170417     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Liver stiffness (LS) correlates with portal pressure (hepatic venous pressure gradient, HVPG). However, the dynamic components of portal hypertension (PHT) in advanced cirrhosis may not be adequately assessed by TE. The influence of treatment with non-selective β-blockers (NSBB) on the correlation of HVPG and LS has not been investigated.
METHODS: One hundred and twenty-two patients with esophageal varices were included. LS, hemodynamic parameters, and HVPG were recorded at baseline (BL) and after 6 weeks of treatment with NSBB (FU). The correlation of LS and HVPG was compared to control patients with HVPG ≤ 12 mmHg.
RESULTS: Patients with higher Child-Pugh stages (A:88/B:25/C:9) had higher levels of liver stiffness (47.4 ± 16.5 vs. 70.3 ± 7.9 vs. 73.7 ± 2.1 kPa) and HVPG (21 ± 5 vs. 26 ± 5 vs. 26 ± 4 mmHg). The correlation of LS and HVPG was stronger in controls with HVPG ≤ 12 mmHg (R = 0.951; P < 0.0001) than in patients with HVPG > 12 mmHg (R = 0.538; P = 0.0004). The association of HVPG with LS became stronger under treatment with NSBB, which finally restored the linear correlation of HVPG and LS (R = 0.930; P < 0.0001). Forty-three percent (53/122) of patients were hemodynamic responders to NSBB. The improvement in the correlation of LS and HVPG under NSBB was mainly noted in hemodynamic responders (R = 0.864), but not in nonresponders (R = 0.535), whereas changes in LS, heart rate, and MAP were similar in responders and nonresponders.
CONCLUSIONS: Targeting the hyperdynamic circulation and the increased splanchnic blood inflow by treatment with NSBB unmasks the linear (mechanical) correlation of HVPG and LS in patients with HVPG > 12 mmHg. Measurement of LS by TE is not a feasible method to assess the dynamic components of PHT.
T Reiberger; A Ferlitsch; B A Payer; M Pinter; M Homoncik; M Peck-Radosavljevic;
Related Documents :
11009457 - Validation of a mouse conductance system to determine lv volume: comparison to echocard...
1777957 - Total body blood volume redistribution in porcine e. coli septic shock: effect of volum...
21930367 - Patient- and physician-level determinants of blood pressure response to treatment in no...
22111777 - Valsartan/amlodipine single pill combination for the treatment of hypertension.
12511747 - Autoregulatory response and co2 reactivity of the basilar artery.
3128527 - Effects of nasal cold receptors on pattern of breathing.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-12-15
Journal Detail:
Title:  Journal of gastroenterology     Volume:  47     ISSN:  1435-5922     ISO Abbreviation:  J. Gastroenterol.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-05-28     Completed Date:  2012-09-13     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  9430794     Medline TA:  J Gastroenterol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  561-8     Citation Subset:  IM    
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University Vienna, Waehringer Guertel 18-20, Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / pharmacology*,  therapeutic use
Carbazoles / pharmacology,  therapeutic use
Elasticity / drug effects
Elasticity Imaging Techniques / methods
Esophageal and Gastric Varices / complications,  physiopathology
Feasibility Studies
Gastrointestinal Hemorrhage / etiology,  physiopathology,  prevention & control
Hemodynamics / drug effects,  physiology
Hypertension, Portal / etiology,  physiopathology,  ultrasonography
Liver / physiopathology*
Liver Cirrhosis / complications,  drug therapy*,  physiopathology,  ultrasonography
Middle Aged
Portal Pressure / drug effects*,  physiology
Propanolamines / pharmacology,  therapeutic use
Propranolol / pharmacology,  therapeutic use
Prospective Studies
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 0K47UL67F2/carvedilol; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve.
Next Document:  Activation of Diboron Reagents with Brønsted Bases and Alcohols: An Experimental and Theoretical Pe...